Investing.com7d agobearish
Citi downgrades Boston Scientific on uncertain recovery pathInvesting.com -- Citi has downgraded Boston Scientific to Neutral from Buy, citing an uncertain recovery path after a string of setbacks this year.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
131last 24h
864last 7d
142● bullish (7d)
100● bearish (7d)
214publishers